MannKind Corp. (NASDAQ:MNKD) on Sept. 29 announced that it had received a $150 million upfront payment in connection with an exclusive worldwide collaboration and licensing agreement with Sanofi for development and commercialization of Afrezza(R) (insulin human) Inhalation Powder, a new rapid-acting inhaled insulin therapy for adults with type 1 and type 2 diabetes. MannKind Corp. (NASDAQ:MNKD) in last trading activity decreased -1.07% to close at $5.55. Company weekly performance is 11.67% while its quarterly performance stands at -43.37%. MannKind Corp. (NASDAQ:MNKD) is -51.66% away from its 52 week high.Geron Corporation (NASDAQ:GERN) aims to post its Q3 earnings results on 3rd November, 2014. The firm shares lifted 10.70% in last trading session. Geron Corporation (Geron) is a clinical-stage biopharmaceutical corporation raising a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. On last trading day Geron Corporation (NASDAQ:GERN) advanced 6.28% to close at $2.20. Its volatility for the week is 9.92% while volatility for the month is 6.87%. GERN's sales growth for past 5 years was -14.20% and its EPS growth for past 5 years was 17.60%. Geron Corporation (NASDAQ:GERN) monthly performance is -5.98%.Hemispherx BioPharma, Inc (NYSEMKT:HEB) gained nearly 16 percent during premarket trading on 13th October after it announced last week. The investor interest in the stock has peaked on the back of numerous positive announcements coming out of the company news room. The most recent was released last week, when it announced that its lead investigator and Director Dr. William Mitchell, Ph.D., had chaired three discussion groups during the 4th World Congress on Virology. On last trading day Hemispherx Biopharma, Inc. (NYSEMKT:HEB) decreased -2.73% to close at $0.32. Its volatility for the week is 11.13% while volatility for the month is 10.34%. HEB's sales growth for past 5 years was -7.80% and its EPS growth for past 5 years was 9.00%. Hemispherx Biopharma, Inc. (NYSEMKT:HEB) monthly performance is -5.59%.On 22 October 2014 AT&T Inc. (NYSE:T) reports quarterly financial results after the market closes. AT&T, Inc. (NYSE:T) in last trading activity decreased -0.68% to close at $33.64. Company weekly performance is -2.94% while its quarterly performance stands at -5.77%. AT&T, Inc. (NYSE:T) is -9.05% away from its 52 week high.Medifast, Inc. (NYSE:MED), the Owings Mills, Maryland-based marketer of weight-loss products and programs, has selected Baltimore-based ad shop GKV as its Agency of Record after a review, the company confirmed Wednesday. On Thursday shares of Medifast Inc. (NYSE:MED) closed at $31.38. Company's sales growth for last 5 years was 26.50% and EPS growth for next 5 years is recorded as 17.00%.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
